SCHEMBL25574262

SCHEMBL25574262

O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N1CCc2ccncc2C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR142 Q7Z601 2/20 0.57
MAPT P10636 2/20 0.55
HTR2C P28335 2/20 0.51
HTR2A P28223 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TRPV1 Q8NER1 3/20 0.49
NAMPT P43490 4/20 0.48
EPHX2 P34913 1/20 0.48
SLC6A3 Q01959 1/20 0.48
KDR P35968 1/20 0.48
CYP1A2 P05177 1/20 0.48
GRIN2B Q13224 1/20 0.48
NPC1 O15118 1/20 0.47
CASP3 P42574 1/20 0.47
RAB9A P51151 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25574260 0.96 MAPT (0.55) GPR142MAPTHTR2CHTR2ASMN1; SMN2
SCHEMBL25574265 0.92 GPR142 (0.57) GPR142HTR2CHTR2ATRPV1NAMPT
SCHEMBL25208366 0.88 GPR142 (0.55) GPR142HTR2CHTR2ATRPV1NAMPT
SCHEMBL25218725 0.87 GPR142 (0.73) GPR142MAPTTRPV1NAMPTNPC1
SCHEMBL25574412 0.86 KMT2A (0.65) MAPTSMN1; SMN2NAMPTEPHX2GRIN2B
SCHEMBL25574253 0.84 MAPT (0.53) GPR142MAPTHTR2CHTR2ASMN1; SMN2
SCHEMBL25574257 0.84 MAPT (0.53) GPR142MAPTSMN1; SMN2NPSR1TRPV1
SCHEMBL25574288 0.83 SLC6A3 (0.57) GPR142MAPTSMN1; SMN2NPSR1TRPV1
SCHEMBL25209775 0.83 GPR142 (0.70) GPR142MAPTTRPV1NAMPTNPC1
SCHEMBL25574313 0.82 MEN1 (0.56) GPR142MAPTSMN1; SMN2NPSR1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174530-A1 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 Pathios Therapeutics Limited (GB) 2023-06-08 US disclosed
US-20230174530-A1 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 Pathios Therapeutics Limited (GB) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174530-A1 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 GPR3, GPR65, GPR52 GPR142 40/4885MAPT 4712/4885HTR2C 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.